The Integration of Novel Approaches in Laboratory Medicine into Precision Pharmacotherapy

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 33

Special Issue Editor


E-Mail Website
Guest Editor
Department of Laboratory Medicine, Semmelweis University, 1089 Budapest, Hungary
Interests: therapeutic drug monitoring; pharmacokinetics; liquid chromatography; mass spectrometry
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In the past few decades, laboratory medicine has evolved into a multidisciplinary field, with an abundance of various approaches having become available to support the screening, diagnosis, monitoring and prognostics of human diseases. The routine laboratory toolkit now comprises automated and special clinical chemistry, hematology, hemostasis, immunology, genetics and microbiology, and the integrated application of skills related to these disciplines is of increasing interest in clinical care. Relevant clinical areas include PK-PD-guided antibiotic treatment, biological therapies, organ transplant, targeted therapies in oncology, or the laboratory assessment of adverse drug effects. As a result, the pharmaceutical community is increasingly recognizing the importance of having skills related to laboratory and point-of-care investigations.

Bioinformatics is an essential tool used to integrate the results of laboratory assays into precision pharmacotherapy. Its importance is particularly prevalent in pharmacokinetic and pharmacodynamic analyses, omics, and the analysis of big datasets for identifying confounding biomarkers for diagnosing a pathological condition, as well as for revealing adverse drug effects. In addition, machine learning tools and artificial intelligence define new dimensions of processing laboratory data, and one of the most notable fields that can benefit from this revolution is pharmacotherapy.

The aim of this Special Issue is to widen the scope of precision pharmacotherapy by highlighting the application of state-of-the-art or novel multidisciplinary laboratory methodology integrated with contemporary bioinformatics to support decision making in clinical pharmacokinetics, clinical pharmacodynamics, and the management of drug administration. The Guest Editor hopes that the articles appearing in this Special Issue will contribute to the integration of knowledge pertaining to pharmaceutics and laboratory medicine for the benefit of patients.

Dr. Gellért Balázs Karvaly
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • therapeutic drug monitoring
  • pharmacokinetics
  • pharmacodynamics
  • bioinformatics
  • clinical chemistry
  • mass spectrometry
  • immunology
  • clinical genetics
  • antiinfectives
  • artificial intelligence

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop